Announcements Trials
Browse Landscape Eligibility

Clinical Trials

2 trials
RecentStart dateEnrollment
PD-1 × Clear all

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 10998Neoplasms 8807Carcinoma, Non-Small-Cell Lung 5711Prostatic Neoplasms 5278Colorectal Neoplasms 4951Lung Neoplasms 4210Pancreatic Neoplasms 3003Multiple Myeloma 3001Neoplasm Metastasis 2954Leukemia, Myeloid, Acute 2927Carcinoma, Hepatocellular 2734Ovarian Neoplasms 2657Melanoma 2635Stomach Neoplasms 2567Lymphoma 2502Head and Neck Neoplasms 2162Recurrence 2132Precursor Cell Lymphoblastic Leukemia-Lymphoma 2069Leukemia 1992Brain Neoplasms 1971Colonic Neoplasms 1939Lymphoma, Non-Hodgkin 1894Rectal Neoplasms 1846Uterine Cervical Neoplasms 1806Glioblastoma 1699Leukemia, Lymphocytic, Chronic, B-Cell 1663Carcinoma, Renal Cell 1597Squamous Cell Carcinoma of Head and Neck 1550Lymphoma, Follicular 1526Esophageal Neoplasms 1516

Interventions

toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06250894 2024-02-09

Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
32 enrolled
Gastrointestinal

PD-1

NCT04061928 2019-08-20

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Peking University

Phase 1/2 Unknown
45 enrolled
Gastrointestinal

PD-1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡